Cargando…
Plasma Prokineticin 1, a prognostic biomarker in colorectal cancer patients with curative resection: a retrospective cohort study
BACKGROUND: Prokineticin 1 (PROK1) was reported as an angiogenic factor, which is associated with tumor progression, cell invasion, and metastasis in colorectal cancer. Although the association between PROK1 expression in primary cancer lesion and patient prognosis was reported, it is unclear whethe...
Autores principales: | Tagai, Noriyuki, Goi, Takanori, Shimada, Michiaki, Kurebayashi, Hidetaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522247/ https://www.ncbi.nlm.nih.gov/pubmed/34657605 http://dx.doi.org/10.1186/s12957-021-02421-0 |
Ejemplares similares
-
Prokineticin 2 (PROK2) is an important factor for angiogenesis in colorectal cancer
por: Kurebayashi, Hidetaka, et al.
Publicado: (2015) -
Prokineticin 2 expression as a novel prognostic biomarker for human colorectal cancer
por: Yoshida, Yu, et al.
Publicado: (2018) -
Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer
por: Goi, Takanori, et al.
Publicado: (2015) -
Follicular cholangitis mimicking a common bile duct cancer: a case report
por: Koneri, Kenji, et al.
Publicado: (2023) -
Prokineticin-1 induces normal lymphangiogenic activity and is involved in lymphangiogenesis and lymph node metastasis in colorectal cancer
por: Naruse, Takayuki, et al.
Publicado: (2021)